Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ladan Fazli

Showing results (31-40 of 270) with videos related to

Pageof 27
Sort By:
Clinical Genitourinary Cancer|June 22, 2016
Molecular Dissection of Complete Response to Receptor Tyrosine Kinase Inhibition in Type II Papillary Renal Cell CarcinomaMatti Annala, Lucia Nappi, Arun A Azad, et al.
The Journal of Clinical Endocrinology and Metabolism|December 16, 2011
Differential expression of the androgen-conjugating UGT2B15 and UGT2B17 enzymes in prostate tumor cells during cancer progressionSophie Pâquet, Ladan Fazli, Laurent Grosse, et al.
The Prostate|November 11, 2011
Carbidopa enhances antitumoral activity of bicalutamide on the androgen receptor-axis in castration-resistant prostate tumorsChristian Thomas, Latif A Wafa, Francois Lamoureux, et al.
Molecular Cancer Therapeutics|March 18, 2004
Nucleotide-based therapies targeting clusterin chemosensitize human lung adenocarcinoma cells both in vitro and in vivoLaura V July, Eliana Beraldi, Alan So, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
GLI2 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in androgen-independent prostate cancerShintaro Narita, Alan So, Susan Ettinger, et al.
The Prostate|April 25, 2007
Increased expression and differential phosphorylation of stathmin may promote prostate cancer progressionRitwik Ghosh, Guangyu Gu, Erin Tillman, et al.
Cancer Research|September 24, 2016
UGT2B17 Expedites Progression of Castration-Resistant Prostate Cancers by Promoting Ligand-Independent AR SignalingHaolong Li, Ning Xie, Ruiqi Chen, et al.
The Journal of Urology|April 8, 2006
Rh2 synergistically enhances paclitaxel or mitoxantrone in prostate cancer modelsXiaowei Xie, Andy Eberding, Candice Madera, et al.
International Journal of Cancer|September 15, 2005
Cyclin G-associated kinase: a novel androgen receptor-interacting transcriptional coactivator that is overexpressed in hormone refractory prostate cancerMira R Ray, Latif A Wafa, Helen Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2015
Targeting Cancer Stem Cells in Castration-Resistant Prostate CancerEun-Jin Yun, Jiancheng Zhou, Chun-Jung Lin, et al.
Pageof 27

Showing results (31-40 of 270) with videos related to

Sort By:
Pageof 27
Clinical Genitourinary Cancer|June 22, 2016
Molecular Dissection of Complete Response to Receptor Tyrosine Kinase Inhibition in Type II Papillary Renal Cell CarcinomaMatti Annala, Lucia Nappi, Arun A Azad, et al.
The Journal of Clinical Endocrinology and Metabolism|December 16, 2011
Differential expression of the androgen-conjugating UGT2B15 and UGT2B17 enzymes in prostate tumor cells during cancer progressionSophie Pâquet, Ladan Fazli, Laurent Grosse, et al.
The Prostate|November 11, 2011
Carbidopa enhances antitumoral activity of bicalutamide on the androgen receptor-axis in castration-resistant prostate tumorsChristian Thomas, Latif A Wafa, Francois Lamoureux, et al.
Molecular Cancer Therapeutics|March 18, 2004
Nucleotide-based therapies targeting clusterin chemosensitize human lung adenocarcinoma cells both in vitro and in vivoLaura V July, Eliana Beraldi, Alan So, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
GLI2 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in androgen-independent prostate cancerShintaro Narita, Alan So, Susan Ettinger, et al.
The Prostate|April 25, 2007
Increased expression and differential phosphorylation of stathmin may promote prostate cancer progressionRitwik Ghosh, Guangyu Gu, Erin Tillman, et al.
Cancer Research|September 24, 2016
UGT2B17 Expedites Progression of Castration-Resistant Prostate Cancers by Promoting Ligand-Independent AR SignalingHaolong Li, Ning Xie, Ruiqi Chen, et al.
The Journal of Urology|April 8, 2006
Rh2 synergistically enhances paclitaxel or mitoxantrone in prostate cancer modelsXiaowei Xie, Andy Eberding, Candice Madera, et al.
International Journal of Cancer|September 15, 2005
Cyclin G-associated kinase: a novel androgen receptor-interacting transcriptional coactivator that is overexpressed in hormone refractory prostate cancerMira R Ray, Latif A Wafa, Helen Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2015
Targeting Cancer Stem Cells in Castration-Resistant Prostate CancerEun-Jin Yun, Jiancheng Zhou, Chun-Jung Lin, et al.
Pageof 27